We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · March 25, 2021

Aflibercept vs Photocoagulation in Diabetic Retinopathy

JAMA ophthalmology


Additional Info

JAMA ophthalmology
Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
JAMA Ophthalmol 2021 Mar 11;[EPub Ahead of Print], S Halim, M Nugawela, U Chakravarthy, T Peto, S Madhusudhan, P Lenfestey, B Hamill, Y Zheng, D Parry, L Nicholson, J Greenwood, S Sivaprasad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading